| Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. |
2020-02-20 |
| France Biotech. (2/19/20). "Press Release: Driven by Its Successful Debut, the Second Annual International HealthTech Innovation Days Will Take Place in Paris on June 22nd & 23rd". Paris. |
2020-02-19 |
| Cellectis S.A.. (2/18/20). "Press Release: Cellectis and Servier Expand Collaboration on UCART19 Products". New York, NY. |
2020-02-18 |
| Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. |
2020-02-18 |
| Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. |
2020-02-17 |
| TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. |
2020-02-17 |
| PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. |
2020-02-17 |
| Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. |
2020-02-17 |
| Rentschler Biopharma SE. (2/13/20). "Press Release: Rentschler Biopharma Adds Senior Executive to Growing U.S. Team. Grace Kim Joins as Vice President Business Development – North America and APAC". Laupheim & Milford, MA. |
2020-02-13 |
| Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. |
2020-02-13 |
| ProteoMedix AG. (2/11/20). "Press Release: New Data from Proclarix together with Magnetic Resonance Imaging (MRI) for Improved Prostate Cancer Diagnosis to Be Showcased at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium". Zür |
2020-02-11 |
| Stilla Technologies S.A.S.. (2/11/20). "Press Release: Stilla Technologies Raises €20 Million ($22 Million) in Series B Round that Brings in New Investor, TUS-Holdings, alongside Existing Ones". Paris. |
2020-02-11 |
| Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. |
2020-02-10 |
| ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. |
2020-02-10 |
| Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. |
2020-02-07 |
| Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. |
2020-02-06 |
| Agilent Technologies Inc.. (2/6/20). "Press Release: Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation". Santa Clara, CA. |
2020-02-06 |
| Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. |
2020-02-06 |
| Illumina, Inc.. (2/6/20). "Press Release: Dr. Scott Gottlieb, Former US FDA Commissioner, Joins Illumina’s Board of Directors". San Diego, CA. |
2020-02-06 |
| Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. |
2020-02-05 |
| Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb7195 for the Development of Next-Generation Food Allergy Treatments". Brisbane, CA. |
2020-02-05 |
| MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. |
2020-02-05 |
| MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. |
2020-02-04 |
| Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. |
2020-02-04 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. |
2020-02-03 |
| Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. |
2020-02-03 |
| Stalicla S.A.. (2/3/20). "Press Release: Swiss Biotech Stalicla Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A". Geneva. |
2020-02-03 |
| Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. |
2020-02-03 |
| Valneva S.E.. (2/3/20). "Press Release: Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed". Saint-Herblain. |
2020-02-03 |
| Aimmune Therapeutics, Inc.. (1/31/20). "Press Release: FDA Approves Aimmune’s Palforzia as First Treatment for Peanut Allergy". Brisbane, CA. |
2020-01-31 |
| CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. |
2020-01-31 |
| Bayer AG. (1/31/20). "Press Release: Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic". Whippany, NJ. |
2020-01-31 |
| Vizgen. (1/30/20). "Press Release: Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures". Cambridge, MA. |
2020-01-30 |
| Mammoth Biosciences, Inc.. (1/30/20). "Press Release: Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products for Therapeutics and Diagnostics". South San Francisco, CA. |
2020-01-30 |
| Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. |
2020-01-27 |
| Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris. |
2020-01-24 |
| Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. |
2020-01-24 |
| Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. |
2020-01-23 |
| PureTech Health plc. (1/23/20). "Press Release: PureTech Receives $200 Million from Sale of a Minority Portion of Affiliate Shares". |
2020-01-23 |
| Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil. |
2020-01-23 |
| Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". |
2020-01-22 |
| Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. |
2020-01-21 |
| Bio-Techne Corporation. (1/21/20). "Press Release: Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies". Miami, FL. |
2020-01-21 |
| Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". |
2020-01-21 |
| Clarivate Analytics plc. (1/17/20). "Press Release: Clarivate Analytics to Acquire Decision Resources Group, Creating a Leading Global Provider of Data-Driven Solutions to the Life Sciences Industry". London & Philadelphia, PA. |
2020-01-17 |
| ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. |
2020-01-17 |
| Charles River Laboratories International, Inc.. (1/16/20). "Press Release: Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment". Wilmington, MA & Edinburgh. |
2020-01-16 |
| Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. |
2020-01-16 |
| BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. |
2020-01-16 |
| Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA. |
2020-01-15 |
| Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. |
2020-01-15 |
| DNA Script. (1/15/20). "Press Release: IARPA Funds Team Involving DNA Script, the Broad Institute, and Harvard University for DNA Data Storage Research and Development". South San Francisco, CA. |
2020-01-15 |
| Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. |
2020-01-15 |
| Valneva S.E.. (1/14/20). "Press Release: US DoD Exercises Option on Ixiaro Supply Contract Bringing Total Value to $70 Million". Saint-Herblain. |
2020-01-14 |
| Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. |
2020-01-14 |
| Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. |
2020-01-14 |
| MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. |
2020-01-13 |
| ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. |
2020-01-13 |
| KCR S.A.. (1/13/20). "Press Release: KCR Announces New Chief Commercial Officer. Bryan Katz Joins KCR’s Growing Executive Team to Take Over as Head of Commercial Strategy and Global Partnerships". Boston, MA. |
2020-01-13 |
| Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. |
2020-01-13 |
| Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. |
2020-01-13 |
| BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. |
2020-01-13 |
| Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. |
2020-01-13 |
| Roche. (1/13/20). "Press Release: Roche and Illumina Partner to Broaden Patient Access to Genomic Testing". Basel. |
2020-01-13 |
| Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY. |
2020-01-12 |
| EQRx, Inc.. (1/12/20). "Press Release: EQRx Launches to Create Innovative Medicines at Dramatically Lower Prices for People, Healthcare Systems and Society". Cambridge, MA. |
2020-01-12 |
| Tyra Biosciences, Inc.. (1/10/20). "Press Release: Tyra Biosciences Raises $50m to Develop Therapies Targeting Acquired Resistance in Oncology". Carlsbad, CA. |
2020-01-10 |
| Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. |
2020-01-10 |
| Eli Lilly and Company. (1/10/20). "Press Release: Lilly Announces Agreement to Acquire Dermira". Indianapolis, IN & Menlo Park, CA. |
2020-01-10 |
| Emergex Vaccines Holding Ltd.. (1/9/20). "Press Release: Emergex Raises more than US$11 Million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases". Abingdon. |
2020-01-09 |
| Omniome, Inc.. (1/9/20). "Press Release: Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform". San Diego, CA. |
2020-01-09 |
| Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. |
2020-01-09 |
| Element Biosciences, Inc.. (1/9/20). "Press Release: Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform". San Diego, CA. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. |
2020-01-09 |
| Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. |
2020-01-09 |
| Nurix Therapeutics, Inc.. (1/9/20). "Press Release: Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies". San Francisco, CA. |
2020-01-09 |
| Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. |
2020-01-09 |
| Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. |
2020-01-09 |
| GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. |
2020-01-08 |
| NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. |
2020-01-08 |
| BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. |
2020-01-08 |
| Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. |
2020-01-08 |
| ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. |
2020-01-07 |
| Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. |
2020-01-07 |
| Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. |
2020-01-07 |
| VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. |
2020-01-07 |
| Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. |
2020-01-07 |
| Novome Biotechnologies, Inc.. (1/7/20). "Press Release: Novome Biotechnologies Raises $33 Million Series A Financing and Appoints Blake Wise as Chief Executive Officer". South San Francisco, CA. |
2020-01-07 |
| Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. |
2020-01-06 |
| MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. |
2019-12-30 |
| Elpiscience Biopharma. (12/28/19). "Press Release: Elpiscience Completes Series B Financing of USD $100 Million". Shanghai. |
2019-12-28 |
| Astellas Pharma Inc.. (12/27/19). "Pressemitteilung: Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.". Tokyo & South San Francisco, CA. |
2019-12-27 |
| Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. |
2019-12-23 |
| Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX. |
2019-12-20 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-12-20 |
| Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. |
2019-12-20 |
| Forma Therapeutics, Inc.. (12/19/19). "Press Release: Forma Therapeutics Announces Closing of $100 Million Series D Financing". Watertown, MA. |
2019-12-19 |
| Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. |
2019-12-19 |
| Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. |
2019-12-19 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
